Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Quantum Computing Inc (QUBT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Quantum Computing Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.62 (market cap $31.07B), while Quantum Computing Inc trades at $6.26 (market cap $1.56B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 19.9× Quantum Computing Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Quantum Computing Inc pays none. Which is the better fit depends on your goals.
| GEHC | QUBT | |
|---|---|---|
Market Cap | $31.07B | $1.56B |
Volume | 3,443,020 | 6,616,227 |
Sector | Health | Technology |
52-Week High | $88.16 | $21.23 |
52-Week Low | $59.48 | $6.31 |
Enterprise Value | $39.53B | $621.96M |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 26 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Quantum Computing Inc. (QUBT) trades at $6.87, down 0.87% on the day, with a bearish technical signal despite bullish oscillators. The company shows explosive revenue growth from $682K in 2025 to $10M projected for 2026, but remains deeply unprofitable with a -152.45% net margin. Recent developments include the Dirac-3S quantum system launch and a $42.5M backlog, though rising expenses and cash burn persist.
While analyst consensus is bullish with a $17.33 price target (75% buy ratings), QUBT faces significant execution risks as it scales quantum hardware production. The stock offers substantial upside potential if commercialization succeeds but carries high volatility given pre-profitability status and competitive quantum computing landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Quantum Computing Inc
Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →
